Filing Details
- Accession Number:
- 0001140361-18-011285
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-01 17:03:06
- Reporting Period:
- 2018-02-27
- Accepted Time:
- 2018-03-01 17:03:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1514588 | Adam Havey | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | Evp, Business Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-02-27 | 5,036 | $0.00 | 31,082 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2018-02-27 | 5,036 | $0.00 | 36,118 | No | 4 | A | Direct | |
Common Stock | Disposition | 2018-02-27 | 409 | $49.64 | 35,709 | No | 4 | F | Direct | |
Common Stock | Disposition | 2018-02-28 | 811 | $49.97 | 34,898 | No | 4 | F | Direct | |
Common Stock | Disposition | 2018-03-01 | 1,898 | $49.50 | 33,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | A | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy | Acquisiton | 2018-02-27 | 20,145 | $49.64 | 20,145 | $49.64 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
20,145 | 2025-02-26 | No | 4 | A | Direct |
Footnotes
- Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
- These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
- Consists of performance stock units granted under the Amended and Restated 2006 Emergent BioSolutions Inc. Stock Incentive Plan, as amended. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to net income as a percentage of total revenue for the 2020 fiscal year, each as determined in accordance with GAAP, as certified by the Compensation Committee following the performance period.
- Vests in three equal installments on February 26, 2019, February 26, 2020 and February 26, 2021.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.